76 related articles for article (PubMed ID: 25789763)
1. Expression of c-fos was associated with clinicopathologic characteristics and prognosis in pancreatic cancer.
Guo JC; Li J; Zhao YP; Zhou L; Cui QC; Zhou WX; Zhang TP; You L
PLoS One; 2015; 10(3):e0120332. PubMed ID: 25789763
[TBL] [Abstract][Full Text] [Related]
2. Correlation between the rs7101 and rs1063169 polymorphisms in the FOS noncoding region and susceptibility to and prognosis of colorectal cancer.
Chen H; Ji L; Liu X; Zhong J
Medicine (Baltimore); 2019 Jun; 98(26):e16131. PubMed ID: 31261535
[TBL] [Abstract][Full Text] [Related]
3. Novel potential biomarkers for pancreatic cancer - A systematic review.
Litman-Zawadzka A; Łukaszewicz-Zając M; Mroczko B
Adv Med Sci; 2019 Sep; 64(2):252-257. PubMed ID: 30844662
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer: A matter of timing.
Seton-Rogers S
Nat Rev Cancer; 2015 May; 15(5):256-7. PubMed ID: 25855403
[No Abstract] [Full Text] [Related]
5. c-Fos separation from Lamin A/C by GDF15 promotes colon cancer invasion and metastasis in inflammatory microenvironment.
Ding Y; Hao K; Li Z; Ma R; Zhou Y; Zhou Z; Wei M; Liao Y; Dai Y; Yang Y; Zhang X; Zhao L
J Cell Physiol; 2020 May; 235(5):4407-4421. PubMed ID: 31613004
[TBL] [Abstract][Full Text] [Related]
6. Phylogenetic and Expression Analysis of Fos Transcription Factors in Zebrafish.
Kubra K; Gaddu GK; Liongue C; Heidary S; Ward AC; Dhillon AS; Basheer F
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077499
[TBL] [Abstract][Full Text] [Related]
7. Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway.
Zou X; Zhou Q; Nie Y; Gou J; Yang J; Zhu J; Li Z; Gong Y
BMC Cancer; 2022 May; 22(1):595. PubMed ID: 35641944
[TBL] [Abstract][Full Text] [Related]
8. The Adipokine Component in the Molecular Regulation of Cancer Cell Survival, Proliferation and Metastasis.
Umar MI; Hassan W; Murtaza G; Buabeid M; Arafa E; Irfan HM; Asmawi MZ; Huang X
Pathol Oncol Res; 2021; 27():1609828. PubMed ID: 34588926
[TBL] [Abstract][Full Text] [Related]
9. Prediction and identification of synergistic compound combinations against pancreatic cancer cells.
KalantarMotamedi Y; Choi RJ; Koh SB; Bramhall JL; Fan TP; Bender A
iScience; 2021 Sep; 24(9):103080. PubMed ID: 34585118
[TBL] [Abstract][Full Text] [Related]
10. Targeting AP-1 transcription factors by CRISPR in the prostate.
Riedel M; Cai H; Stoltze IC; Vendelbo MH; Wagner EF; Bakiri L; Thomsen MK
Oncotarget; 2021 Sep; 12(19):1956-1961. PubMed ID: 34548912
[TBL] [Abstract][Full Text] [Related]
11. Selective antagonism of cJun for cancer therapy.
Brennan A; Leech JT; Kad NM; Mason JM
J Exp Clin Cancer Res; 2020 Sep; 39(1):184. PubMed ID: 32917236
[TBL] [Abstract][Full Text] [Related]
12. Nuclear Tau, p53 and Pin1 Regulate PARN-Mediated Deadenylation and Gene Expression.
Baquero J; Varriano S; Ordonez M; Kuczaj P; Murphy MR; Aruggoda G; Lundine D; Morozova V; Makki AE; Alonso ADC; Kleiman FE
Front Mol Neurosci; 2019; 12():242. PubMed ID: 31749682
[TBL] [Abstract][Full Text] [Related]
13. Chemerin and Cancer.
Treeck O; Buechler C; Ortmann O
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370263
[TBL] [Abstract][Full Text] [Related]
14. Targeting acquired oncogenic burden in resilient pancreatic cancer: a novel benefit from marine polyphenols.
Aravindan S; Somasundaram DB; Somasundaram ST; Natarajan M; Herman TS; Aravindan N
Mol Cell Biochem; 2019 Oct; 460(1-2):175-193. PubMed ID: 31367889
[TBL] [Abstract][Full Text] [Related]
15. DNA hypermethylation of aurora kinase A in hepatitis C virus‑positive hepatocellular carcinoma.
Ma Z; Liu Y; Hao Z; Hua X; Li W
Mol Med Rep; 2019 Sep; 20(3):2519-2532. PubMed ID: 31322223
[TBL] [Abstract][Full Text] [Related]
16. EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signaling.
Linder M; Glitzner E; Srivatsa S; Bakiri L; Matsuoka K; Shahrouzi P; Dumanic M; Novoszel P; Mohr T; Langer O; Wanek T; Mitterhauser M; Wagner EF; Sibilia M
EMBO Mol Med; 2018 Nov; 10(11):. PubMed ID: 30361264
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Transcription Factor-Related Regulatory Networks Based on Bioinformatics Analysis and Validation in Hepatocellular Carcinoma.
Liu S; Yao X; Zhang D; Sheng J; Wen X; Wang Q; Chen G; Li Z; Du Z; Zhang X
Biomed Res Int; 2018; 2018():1431396. PubMed ID: 30228980
[TBL] [Abstract][Full Text] [Related]
18. C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance.
Li G; Hu X; Sun L; Li X; Li J; Li T; Zhang X
Cell Mol Biol Lett; 2018; 23():6. PubMed ID: 29483928
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of normal adjacent to tumor transcriptomes.
Aran D; Camarda R; Odegaard J; Paik H; Oskotsky B; Krings G; Goga A; Sirota M; Butte AJ
Nat Commun; 2017 Oct; 8(1):1077. PubMed ID: 29057876
[TBL] [Abstract][Full Text] [Related]
20. c-Fos over-expression promotes radioresistance and predicts poor prognosis in malignant glioma.
Liu ZG; Jiang G; Tang J; Wang H; Feng G; Chen F; Tu Z; Liu G; Zhao Y; Peng MJ; He ZW; Chen XY; Lindsay H; Xia YF; Li XN
Oncotarget; 2016 Oct; 7(40):65946-65956. PubMed ID: 27602752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
